Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Articles and issues > Author index
Search
Yong Sun Yoo 1 Article
Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
Sunok Park, Kyeong Min Lee, Yong Sun Yoo, Jung Sik Yoo, Jae Il Yoo, Hwa Su Kim, Yeong Seon Lee, Gyung Tae Chung
Osong Public Health Res Perspect. 2011;2(3):164-170.   Published online December 31, 2011
DOI: https://doi.org/10.1016/j.phrp.2011.11.040
  • 1,837 View
  • 14 Download
  • 27 Citations
AbstractAbstract PDF
Objectives
This study investigated the fluoroquinolone-resistant mechanism of 56 clinical cases of A baumannii infection from 23 non-tertiary hospitals, collected between 2004 and 2006.
Methods
Susceptibility testing was performed by broth microdilution and Epsilometer test. Analyses of quinolone resistance-determining region (QRDR) were done by sequencing. The activity of the efflux pump was measured using inhibitors.
Results
The sequences from selected 56 isolates were divided into seven groups (I-VII) on the basis of mutations in gyrA (S83L), parC (S80L, S80W and S84K) and gyrB (containing the novel mutations E679D, D644Y and A677V). The 27 isolates with triple mutations in gyrA, gyrB and parC (groups IV-VII) showed higher levels of resistance to ciprofloxacin (minimal inhibitory concentration [MIC] of 16-256 μg/mL) than the 26 isolates with double mutations in gyrA and parC (groups II and III, MIC of 8-64 μ g/mL; p < 0.05). Alterations in the efflux pump were observed in four isolates with the parC S80L mutation (group II) or E84K mutation (group VII), but no effect was observed in an isolate with the parC S80 W mutation (group III).
Conclusion
These results suggest that triple mutations in clinical isolates of A baumannii contribute to the development of high levels of resistance to fluoroquinolones and that mutations in parC S80L or E84K (groups II and VII) may contribute to alterations in efflux pump activity in A baumannii.

Citations

Citations to this article as recorded by  
  • A comprehensive review on potential therapeutic inhibitors of nosocomial Acinetobacter baumannii superbugs
    Danaboina Srikanth, Swanand Vinayak Joshi, Mahammad Ghouse Shaik, Gaurav Pawar, Sushmitha Bujji, Vinaykumar Kanchupalli, Sidharth Chopra, Srinivas Nanduri
    Bioorganic Chemistry.2022; 124: 105849.     CrossRef
  • Differential Binding of Carbapenems with the AdeABC Efflux Pump and Modulation of the Expression of AdeB Linked to Novel Mutations within Two-Component System AdeRS in Carbapenem-Resistant Acinetobacter baumannii
    Subhasree Roy, Vivek Junghare, Shanta Dutta, Saugata Hazra, Sulagna Basu, Christopher W. Marshall
    mSystems.2022;[Epub]     CrossRef
  • Antimicrobial Resistance, Integron Carriage, and Fluoroquinolone Resistance Genes in Acinetobacte baumannii Isolates
    Parastoo Ashouri, Jafar Mohammadshahi, Vajihe Sadat Nikbin, Hadi Peeridogaheh, Behnam Mohammadi-Ghalehbin, Siheila Refahi, Amir Teimourpour, Majid Esmaelizad, Hafez Mirzaneghad, Roghayeh Teimourpour
    Archives of Clinical Infectious Diseases.2022;[Epub]     CrossRef
  • Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors
    Privita Verma, Monalisa Tiwari, Vishvanath Tiwari
    Microbial Pathogenesis.2021; 152: 104766.     CrossRef
  • Overexpression of Efflux Pumps, Mutations in the Pumps’ Regulators, Chromosomal Mutations, and AAC(6′)-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center S
    Subhasree Roy, Somdatta Chatterjee, Amrita Bhattacharjee, Pinaki Chattopadhyay, Bijan Saha, Shanta Dutta, Sulagna Basu
    Frontiers in Microbiology.2021;[Epub]     CrossRef
  • Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens
    Jaime E. Zlamal, Semen A. Leyn, Mallika Iyer, Marinela L. Elane, Nicholas A. Wong, James W. Wamsley, Maarten Vercruysse, Fernando Garcia-Alcalde, Andrei L. Osterman, Igor B. Zhulin
    mBio.2021;[Epub]     CrossRef
  • Efflux Pump Activity and Mutations Driving Multidrug Resistance in Acinetobacter baumannii at a Tertiary Hospital in Pretoria, South Africa
    Noel-David Nogbou, Granny M. Nkawane, Khanyisa Ntshane, Charles K. Wairuri, Dikwata T. Phofa, Kagiso K. Mokgokong, Mbudzeni Ramashia, Maphoshane Nchabeleng, Lawrence C. Obi, Andrew M. Musyoki, Todd R. Callaway
    International Journal of Microbiology.2021; 2021: 1.     CrossRef
  • The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii
    Alejandra Sanchez-Carbonel, Belén Mondragón, Nicolás López-Chegne, Isaac Peña-Tuesta, Gladys Huayan-Dávila, Dora Blitchtein, Hugo Carrillo-Ng, Wilmer Silva-Caso, Miguel Angel Aguilar-Luis, Juana del Valle-Mendoza, Iddya Karunasagar
    PLOS ONE.2021; 16(12): e0259915.     CrossRef
  • Effects of different resistance mechanisms on antimicrobial resistance in Acinetobacter baumannii: a strategic system for screening and activity testing of new antibiotics
    Yu-Kuo Tsai, Ci-Hong Liou, Jung-Chung Lin, Chang-Phone Fung, Feng-Yee Chang, L. Kristopher Siu
    International Journal of Antimicrobial Agents.2020; 55(4): 105918.     CrossRef
  • Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii
    Corneliu Ovidiu Vrancianu, Irina Gheorghe, Ilda Barbu Czobor, Mariana Carmen Chifiriuc
    Microorganisms.2020; 8(6): 935.     CrossRef
  • Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in Acinetobacter baumannii
    Chandler Roe, Charles H. D. Williamson, Adam J. Vazquez, Kristen Kyger, Michael Valentine, Jolene R. Bowers, Paul D. Phillips, Veronica Harrison, Elizabeth Driebe, David M. Engelthaler, Jason W. Sahl
    Frontiers in Public Health.2020;[Epub]     CrossRef
  • Molecular Analyses of Biofilm-Producing Clinical Acinetobacter baumannii Isolates from a South Indian Tertiary Care Hospital
    Balaram Khamari, Manmath Lama, Chanakya Pachi Pulusu, Amarendra Pratap  Biswal, Sai Manoz Lingamallu, Bhargava Sai Mukkirla, Amit Kumar Sahoo, Harioum Sambhu Narayan Dash, Rewa Sharda, Prakash Kumar, Eswarappa Pradeep Bulagonda
    Medical Principles and Practice.2020; 29(6): 580.     CrossRef
  • Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania
    Happiness H Kumburu, Tolbert Sonda, Marco van Zwetselaar, Pimlapas Leekitcharoenphon, Oksana Lukjancenko, Blandina T Mmbaga, Michael Alifrangis, Ole Lund, Frank M Aarestrup, Gibson S Kibiki
    Journal of Antimicrobial Chemotherapy.2019; 74(6): 1484.     CrossRef
  • Phenotypic and Genotypic Characterization of Acinetobacter spp. Panel Strains: A Cornerstone to Facilitate Antimicrobial Development
    Roshan D'Souza, Naina A. Pinto, Nguyen Le Phuong, Paul G. Higgins, Thao Nguyen Vu, Jung-Hyun Byun, Young Lag Cho, Jong Rak Choi, Dongeun Yong
    Frontiers in Microbiology.2019;[Epub]     CrossRef
  • Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat
    David A. Butler, Mark Biagi, Xing Tan, Samah Qasmieh, Zackery P. Bulman, Eric Wenzler
    Current Infectious Disease Reports.2019;[Epub]     CrossRef
  • Molecular Study of Quinolone Resistance Determining Regions of gyrA Gene and parC Genes in Clinical Isolates of Acintobacter baumannii Resistant to Fluoroquinolone
    Maysaa El Sayed Zaki, Nermen Abou ElKheir, Mohamed Mofreh
    The Open Microbiology Journal.2018; 12(1): 116.     CrossRef
  • Species distribution, virulence factors and antimicrobial resistance ofAcinetobacterspp. isolates from dogs and cats: a preliminary study
    Yui Kimura, Kazuki Harada, Takae Shimizu, Tomomi Sato, Akari Kajino, Masaru Usui, Yutaka Tamura, Yuzo Tsuyuki, Tadashi Miyamoto, Asami Ohki, Masahisa Watarai
    Microbiology and Immunology.2018; 62(7): 462.     CrossRef
  • Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients
    Samira M. Hamed, Walid F. Elkhatib, Hadir A. El-Mahallawy, Mai M. Helmy, Mohamed S. Ashour, Khaled M. A. Aboshanab
    Scientific Reports.2018;[Epub]     CrossRef
  • Synthesis and investigation of binding interactions of 1,4-benzoxazine derivatives on topoisomerase IV in Acinetobacter baumannii
    S. Yilmaz, I. Yalcin, S. Okten, F. K. Onurdag, E. Aki-Yalcin
    SAR and QSAR in Environmental Research.2017; 28(11): 941.     CrossRef
  • Antibacterial Resistance in Ureaplasma Species and Mycoplasma hominis Isolates from Urine Cultures in College-Aged Females
    Marissa A. Valentine-King, Mary B. Brown
    Antimicrobial Agents and Chemotherapy.2017;[Epub]     CrossRef
  • MOLECULAR BACKGROUND OF FLUOROQUINOLONE RESISTANCE IN PATHOGENIC HUMAN MYCOPLASMAS
    A. N. Vaganova
    Russian Journal of Infection and Immunity.2017; 7(3): 231.     CrossRef
  • Alarmingly High Segregation Frequencies of Quinolone Resistance Alleles within Human and Animal Microbiomes Are Not Explained by Direct Clinical Antibiotic Exposure
    Wesley Field, Ruth Hershberg
    Genome Biology and Evolution.2015; 7(6): 1743.     CrossRef
  • Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei
    Masayoshi Tojo, Momoko Mawatari, Kayoko Hayakawa, Maki Nagamatsu, Kayo Shimada, Kazuhisa Mezaki, Yuko Sugiki, Emi Kuroda, Nozomi Takeshita, Satoshi Kutsuna, Yoshihiro Fujiya, Tohru Miyoshi-Akiyama, Teruo Kirikae, Norio Ohmagari
    Journal of Infection and Chemotherapy.2015; 21(3): 212.     CrossRef
  • Correlation of Ciprofloxacin Resistance with the AdeABC Efflux System in Acinetobacter baumannii Clinical Isolates
    Abdollah Ardebili, Abdolaziz Rastegar Lari, Malihe Talebi
    Annals of Laboratory Medicine.2014; 34(6): 433.     CrossRef
  • Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates
    Abdollah Ardebili, Malihe Talebi, Leila Azimi, Abdolaziz Rastegar Lari
    Jundishapur Journal of Microbiology.2014;[Epub]     CrossRef
  • Characterization of Acinetobacter baumannii Clinical Isolates Carrying blaOXA-23 Carbapenemase and 16S rRNA Methylase armA genes in Yemen
    Sofiane Bakour, Samer Ahmed Alsharapy, Abdelaziz Touati, Jean-Marc Rolain
    Microbial Drug Resistance.2014; 20(6): 604.     CrossRef
  • First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals
    Sofiane Bakour, Abdelaziz Touati, Taous Bachiri, Farida Sahli, Djamel Tiouit, Malek Naim, Mounia Azouaou, Jean-Marc Rolain
    Journal of Infection and Chemotherapy.2014; 20(11): 696.     CrossRef

PHRP : Osong Public Health and Research Perspectives